OTLK
Outlook Therapeutics
$0.55
+$0.01 (+2.83%)Oct 28, 2026
Key metrics
The numbers that frame OTLK today
- Market cap
- $132.68M
- Gross margin
- 195.6%
- ROIC
- 43,243.8%
- Div yield
- 0%
- 52wk Low
- $0.16
- 52wk High
- $2.54
Growth
Revenue and earnings trend for OTLK
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about OTLK
Is Outlook Therapeutics a good buy?
No. Outlook Therapeutics has excellent momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think Outlook Therapeutics is selling at a very high price.
What is the market capitalization of OTLK?
Outlook Therapeutics's market capitalization is $132.68M.
What is the 52-week high for OTLK stock?
The 52-week high for Outlook Therapeutics is $2.54. The current close of $0.55 is 78.5% below that high.
What is the 52-week low for OTLK stock?
The 52-week low for Outlook Therapeutics is $0.16. The current close of $0.55 is 238.5% above that low.
Does OTLK stock pay dividends?
Outlook Therapeutics does not currently show a dividend per share in the company data.